Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carl Zeiss is a global leader in the development of advanced optical and optoelectronic technology, serving the life sciences, medical technology, and semiconductor industries. The company's Medical Technology segment, primarily through Carl Zeiss Meditec, provides end-to-end solutions for ophthalmology and microsurgery, including surgical microscopes, laser systems, and diagnostic tools. In the life sciences sector, ZEISS is a premier provider of light, electron, and X-ray microscopy systems essential for biological research and drug discovery. Their products are integral to clinical workflows, enabling high-precision diagnostics and minimally invasive treatments. Headquartered in Germany, the company operates as a foundation-owned entity with a significant global footprint in R&D and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on a developer of optical instruments.